TipRanks
Go Ultimate55% OFF

John Vavricka Insider Profile

4 Followers

John Vavricka, CCO at Atea Pharmaceuticals, holds 165.10K shares in Atea Pharmaceuticals (Ticker: AVIR).

John Vavricka's Trading History

AVIR
Atea Pharmaceuticals
Feb 03, 2026CCOUninformative Buy129.38K$676.92K
AVIR
Insider Shares: 165.10K (0.21%)

John Vavricka has not reported any informative transactions for AVIR, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 03, 2026Uninformative Buy$129.38K30,513$4.24―
Feb 04, 2025Uninformative Buy$93.53K30,566$3.06―
Feb 02, 2024Uninformative Buy$89.50K21,515$4.16―
Nov 03, 2020Uninformative Buy$0.0082,508$0.00―

You May Also Like

John Vavricka insider profile FAQ

What stocks does John Vavricka hold?
John Vavricka holds: AVIR stocks.
What was John Vavricka’s latest transaction?
John Vavricka’s latest transaction was an Uninformative Buy of $129.38K.
What is John Vavricka's role in Atea Pharmaceuticals?
John Vavricka's role in Atea Pharmaceuticals is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.